Skip to main content
PMC home page
The Texas Heart Institute Journal logoLink to The Texas Heart Institute Journal
. 1994;21(1):104–111.

Coronary restenosis and gene therapy.

W Mazur 1, N M Ali 1, A E Raizner 1, B A French 1
PMCID: PMC325139  PMID: 8180504

Abstract

Restenosis continues to limit the efficacy of coronary angioplasty, despite the various mechanical and pharmaceutical interventions that have been employed. The migration, proliferation, and extracellular matrix production by vascular smooth muscle cells are processes integral to restenosis, and sustained local delivery of drugs at high concentration should curtail these vascular responses to balloon angioplasty. Our laboratory and others are exploring the potential of using somatic cell gene therapy to provide such treatment and thereby prevent restenosis. However, conventional methods of gene transfer fail to produce physiologic levels of recombinant protein in vivo. This obstacle might be overcome by using adenoviral vectors to mediate efficient direct gene transfer. Herein we summarize these developments and focus upon our laboratory's progress towards evaluating adenovirus-mediated gene therapy in porcine coronary arteries. Recombinant adenoviruses directing the expression of the beta-galactosidase and luciferase reporter genes were evaluated in cultured coronary vascular smooth muscle cells in vitro and in porcine coronary arteries in vivo. Following percutaneous transluminal gene transfer in vivo, recombinant adenoviruses were shown to produce 70- to 240-fold more reporter protein than that produced by Lipofectin-DNA complexes. Furthermore, the high levels of adenovirus-mediated gene expression were shown to persist for at least 14 days following catheterization. Additional histologic studies will be required to determine the cellular distribution of gene expression and to elucidate potential interactions between adenovirus and the host's immune system, but recombinant adenovirus appears to be a promising vector for evaluating gene therapy against coronary restenosis.

Full text

PDF
104

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bittl J. A., Sanborn T. A., Tcheng J. E., Siegel R. M., Ellis S. G. Clinical success, complications and restenosis rates with excimer laser coronary angioplasty. The Percutaneous Excimer Laser Coronary Angioplasty Registry. Am J Cardiol. 1992 Dec 15;70(20):1533–1539. doi: 10.1016/0002-9149(92)90453-6. [DOI] [PubMed] [Google Scholar]
  2. Chapman G. D., Lim C. S., Gammon R. S., Culp S. C., Desper J. S., Bauman R. P., Swain J. L., Stack R. S. Gene transfer into coronary arteries of intact animals with a percutaneous balloon catheter. Circ Res. 1992 Jul;71(1):27–33. doi: 10.1161/01.res.71.1.27. [DOI] [PubMed] [Google Scholar]
  3. Ellis S. G., Roubin G. S., Wilentz J., Douglas J. S., Jr, King S. B., 3rd Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J. 1989 Apr;117(4):777–782. doi: 10.1016/0002-8703(89)90612-1. [DOI] [PubMed] [Google Scholar]
  4. Flugelman M. Y., Jaklitsch M. T., Newman K. D., Casscells W., Bratthauer G. L., Dichek D. A. Low level in vivo gene transfer into the arterial wall through a perforated balloon catheter. Circulation. 1992 Mar;85(3):1110–1117. doi: 10.1161/01.cir.85.3.1110. [DOI] [PubMed] [Google Scholar]
  5. Foley J. B., Penn I. M., Brown R. I., Murray-Parsons N., White J., Galligan L., MacDonald C. Safety, success, and restenosis after elective coronary implantation of the Palmaz-Schatz stent in 100 patients at a single center. Am Heart J. 1993 Mar;125(3):686–694. doi: 10.1016/0002-8703(93)90159-7. [DOI] [PubMed] [Google Scholar]
  6. Forrester J. S., Fishbein M., Helfant R., Fagin J. A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. J Am Coll Cardiol. 1991 Mar 1;17(3):758–769. doi: 10.1016/s0735-1097(10)80196-2. [DOI] [PubMed] [Google Scholar]
  7. Graham F. L., Prevec L. Adenovirus-based expression vectors and recombinant vaccines. Biotechnology. 1992;20:363–390. doi: 10.1016/b978-0-7506-9265-6.50022-1. [DOI] [PubMed] [Google Scholar]
  8. Graham F. L., Smiley J., Russell W. C., Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol. 1977 Jul;36(1):59–74. doi: 10.1099/0022-1317-36-1-59. [DOI] [PubMed] [Google Scholar]
  9. Grigg L. E., Kay T. W., Valentine P. A., Larkins R., Flower D. J., Manolas E. G., O'Dea K., Sinclair A. J., Hopper J. L., Hunt D. Determinants of restenosis and lack of effect of dietary supplementation with eicosapentaenoic acid on the incidence of coronary artery restenosis after angioplasty. J Am Coll Cardiol. 1989 Mar 1;13(3):665–672. doi: 10.1016/0735-1097(89)90609-8. [DOI] [PubMed] [Google Scholar]
  10. Hinohara T., Robertson G. C., Selmon M. R., Vetter J. W., Rowe M. H., Braden L. J., McAuley B. J., Sheehan D. J., Simpson J. B. Restenosis after directional coronary atherectomy. J Am Coll Cardiol. 1992 Sep;20(3):623–632. doi: 10.1016/0735-1097(92)90017-h. [DOI] [PubMed] [Google Scholar]
  11. Ho S. C., Huang L. A novel cytochemical marker for liposome decomposition in lysosomes. J Histochem Cytochem. 1983 Mar;31(3):404–410. doi: 10.1177/31.3.6827078. [DOI] [PubMed] [Google Scholar]
  12. Karas S. P., Gravanis M. B., Santoian E. C., Robinson K. A., Anderberg K. A., King S. B., 3rd Coronary intimal proliferation after balloon injury and stenting in swine: an animal model of restenosis. J Am Coll Cardiol. 1992 Aug;20(2):467–474. doi: 10.1016/0735-1097(92)90119-8. [DOI] [PubMed] [Google Scholar]
  13. Kirshenbaum L. A., MacLellan W. R., Mazur W., French B. A., Schneider M. D. Highly efficient gene transfer into adult ventricular myocytes by recombinant adenovirus. J Clin Invest. 1993 Jul;92(1):381–387. doi: 10.1172/JCI116577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lemarchand P., Jones M., Yamada I., Crystal R. G. In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors. Circ Res. 1993 May;72(5):1132–1138. doi: 10.1161/01.res.72.5.1132. [DOI] [PubMed] [Google Scholar]
  15. Lim C. S., Chapman G. D., Gammon R. S., Muhlestein J. B., Bauman R. P., Stack R. S., Swain J. L. Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog. Circulation. 1991 Jun;83(6):2007–2011. doi: 10.1161/01.cir.83.6.2007. [DOI] [PubMed] [Google Scholar]
  16. MacGregor G. R., Caskey C. T. Construction of plasmids that express E. coli beta-galactosidase in mammalian cells. Nucleic Acids Res. 1989 Mar 25;17(6):2365–2365. doi: 10.1093/nar/17.6.2365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Marsh M., Helenius A. Virus entry into animal cells. Adv Virus Res. 1989;36:107–151. doi: 10.1016/S0065-3527(08)60583-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Martin A., Biol M. C., Richard M., Louisot P. Purification and separation of two soluble fucosyltransferase activities of small intestinal mucosa. Comp Biochem Physiol B. 1987;87(4):725–731. doi: 10.1016/0305-0491(87)90380-4. [DOI] [PubMed] [Google Scholar]
  19. McGrory W. J., Bautista D. S., Graham F. L. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology. 1988 Apr;163(2):614–617. doi: 10.1016/0042-6822(88)90302-9. [DOI] [PubMed] [Google Scholar]
  20. Meidell R. S., Gerard R. D., Williams R. S. The end of the beginning. Gene transfer into the vessel wall. Circulation. 1992 Mar;85(3):1219–1219. doi: 10.1161/01.cir.85.3.1219. [DOI] [PubMed] [Google Scholar]
  21. Mittal S. K., McDermott M. R., Johnson D. C., Prevec L., Graham F. L. Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter. Virus Res. 1993 Apr;28(1):67–90. doi: 10.1016/0168-1702(93)90090-a. [DOI] [PubMed] [Google Scholar]
  22. Muller D. W., Ellis S. G., Topol E. J. Experimental models of coronary artery restenosis. J Am Coll Cardiol. 1992 Feb;19(2):418–432. doi: 10.1016/0735-1097(92)90500-m. [DOI] [PubMed] [Google Scholar]
  23. Murphy J. G., Schwartz R. S., Edwards W. D., Camrud A. R., Vlietstra R. E., Holmes D. R., Jr Percutaneous polymeric stents in porcine coronary arteries. Initial experience with polyethylene terephthalate stents. Circulation. 1992 Nov;86(5):1596–1604. doi: 10.1161/01.cir.86.5.1596. [DOI] [PubMed] [Google Scholar]
  24. Nabel E. G., Plautz G., Nabel G. J. Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science. 1990 Sep 14;249(4974):1285–1288. doi: 10.1126/science.2119055. [DOI] [PubMed] [Google Scholar]
  25. Rodgers G. P., Minor S. T., Robinson K., Cromeens D., Woolbert S. C., Stephens L. C., Guyton J. R., Wright K., Roubin G. S., Raizner A. E. Adjuvant therapy for intracoronary stents. Investigations in atherosclerotic swine. Circulation. 1990 Aug;82(2):560–569. doi: 10.1161/01.cir.82.2.560. [DOI] [PubMed] [Google Scholar]
  26. Rosenfeld M. A., Yoshimura K., Trapnell B. C., Yoneyama K., Rosenthal E. R., Dalemans W., Fukayama M., Bargon J., Stier L. E., Stratford-Perricaudet L. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell. 1992 Jan 10;68(1):143–155. doi: 10.1016/0092-8674(92)90213-v. [DOI] [PubMed] [Google Scholar]
  27. Schneider M. D., French B. A. The advent of adenovirus. Gene therapy for cardiovascular disease. Circulation. 1993 Oct;88(4 Pt 1):1937–1942. doi: 10.1161/01.cir.88.4.1937. [DOI] [PubMed] [Google Scholar]
  28. Schuler G., Hambrecht R., Schlierf G., Niebauer J., Hauer K., Neumann J., Hoberg E., Drinkmann A., Bacher F., Grunze M. Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease. Circulation. 1992 Jul;86(1):1–11. doi: 10.1161/01.cir.86.1.1. [DOI] [PubMed] [Google Scholar]
  29. Schuler G., Hambrecht R., Schlierf G., Niebauer J., Hauer K., Neumann J., Hoberg E., Drinkmann A., Bacher F., Grunze M. Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease. Circulation. 1992 Jul;86(1):1–11. doi: 10.1161/01.cir.86.1.1. [DOI] [PubMed] [Google Scholar]
  30. Schwartz L., Bourassa M. G., Lespérance J., Aldridge H. E., Kazim F., Salvatori V. A., Henderson M., Bonan R., David P. R. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med. 1988 Jun 30;318(26):1714–1719. doi: 10.1056/NEJM198806303182603. [DOI] [PubMed] [Google Scholar]
  31. Schwartz R. S., Murphy J. G., Edwards W. D., Camrud A. R., Vliestra R. E., Holmes D. R. Restenosis after balloon angioplasty. A practical proliferative model in porcine coronary arteries. Circulation. 1990 Dec;82(6):2190–2200. doi: 10.1161/01.cir.82.6.2190. [DOI] [PubMed] [Google Scholar]
  32. Stratford-Perricaudet L. D., Makeh I., Perricaudet M., Briand P. Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest. 1992 Aug;90(2):626–630. doi: 10.1172/JCI115902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Thompson J. F., Hayes L. S., Lloyd D. B. Modulation of firefly luciferase stability and impact on studies of gene regulation. Gene. 1991 Jul 22;103(2):171–177. doi: 10.1016/0378-1119(91)90270-l. [DOI] [PubMed] [Google Scholar]
  34. White J., Helenius A., Gething M. J. Haemagglutinin of influenza virus expressed from a cloned gene promotes membrane fusion. Nature. 1982 Dec 16;300(5893):658–659. doi: 10.1038/300658a0. [DOI] [PubMed] [Google Scholar]
  35. Wolinsky H., Thung S. N. Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery. J Am Coll Cardiol. 1990 Feb;15(2):475–481. doi: 10.1016/s0735-1097(10)80079-8. [DOI] [PubMed] [Google Scholar]
  36. de Wet J. R., Wood K. V., DeLuca M., Helinski D. R., Subramani S. Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol. 1987 Feb;7(2):725–737. doi: 10.1128/mcb.7.2.725. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Texas Heart Institute Journal are provided here courtesy of Texas Heart Institute

RESOURCES